The patients group with the mutant p53 breast tumor-expressing p53γ isoform had low cancer recurrence and an overall survival as good as that of patients with wild-type p53 breast cancer Conversely, patients expressing only mutant p53, without p53γ isoform expression, had a particularly poor prognosis. This evidence concerns the gene TP53 and breast cancer.